LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 269 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 2.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $380,000 | -30.8% | 2,800 | +40.0% | 0.02% | -14.8% |
| Q3 2018 | $549,000 | -24.3% | 2,000 | -42.9% | 0.03% | -30.8% |
| Q2 2018 | $725,000 | +15.4% | 3,500 | -7.9% | 0.04% | +14.7% |
| Q1 2018 | $628,000 | +20.8% | 3,800 | 0.0% | 0.03% | +21.4% |
| Q4 2017 | $520,000 | -22.0% | 3,800 | -22.4% | 0.03% | -22.2% |
| Q3 2017 | $667,000 | +115.2% | 4,900 | +88.5% | 0.04% | +71.4% |
| Q3 2016 | $310,000 | 0.0% | 2,600 | 0.0% | 0.02% | 0.0% |
| Q2 2016 | $310,000 | – | 2,600 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |